RxDoctor Payments Data

Bruce McCormack, MD

Neurological Surgery · San Francisco, CANPI 1184636425

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (45.2%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Providence Medical Technology, Inc. accounts for 99.0% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $27,156 and has fallen 63.9% since, to $9,807 in 2025.

$73,912in general payments, 2019–2025

Across 71 payments — averaging $1041.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Providence Medical Technology, Inc.$73K
  • Alphatec Spine, Inc$208
  • Centinel Spine, LLC$189
  • Abbott$81
  • Johnson & Johnson$71
  • Spinal Elements, Inc.$54
  • plus $152 from 5 others
$3,870,881in ownership & investment interests, 2019–2025

Across 6 payments — averaging $645,147 each. An ownership or investment interest held by the physician or an immediate family member.

  • Providence Medical Technology, Inc.$3.9M

What the payments were for

  • Consulting fees$25,98135%
  • Speaking & faculty fees$5,1287%
  • Travel & lodging$33,41245%
  • Food & beverage$9,39213%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$73,912 in reported general payments places this provider in the 85th percentile of 773 neurological surgery providers in California.

See all neurological surgery providers in California

Medicare billing

Part B allowed, 2024
$182,287
Medicare patients
254
Services billed
635

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen39$538
Gabapentin13$129
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen14$124
Oxycodone Hcl14$114
Methylprednisolone11$57

Paid to pharmacies, not to this prescriber.

Other neurological surgery in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →